THRIVE has a multi-faceted, collaborative leadership and working group structure that will help ensure the success of the trial.
For general THRIVE inquiries, please contact askthrive@umich.edu.
Operational Structure
Data Coordinating Center (DCC)
The Data Coordinating Center (DCC) is based at the University of Michigan and will provide leadership regarding the analytical, statistical, and data management for the THRIVE study, including areas such as study design and oversight, enrollment reporting, statistical analysis, and data collection.
DCC Program Manager
Chelsea Cloyd, MBA
DCC/MPOG Program Manager
Shelley Vaughn, MPH
DCC Faculty Lead
Sachin Kheterpal, MD MBA
Clinical Coordinating Center (CCC)
The Clinical Coordinating Center (CCC) has representation from several THRIVE sites (e.g. Washington University, University of Michigan, University of Pennsylvania, Stanford University) and will manage processes related to patient enrollment and study coordinator training in order to ensure patient-centered and rigorous trial execution.
CCC Program Manager
Laura Swisher, MS
CCC Co-Investigator
Bethany Pennington, PharmD, BCPS
CCC Faculty Lead
Michael Avidan, MBBCh
Patient Partnership & Engagement
Patient Partnership & Engagement is a crucial component of the THRIVE trial. The patient partners bring lived experiences and will be engaged in planning activities throughout all phases of the trial. To operationalize this an intricately designed structure has been developed including:
The Patient Partnership Leadership Center (PPLC) will serve as an innovation and methods core to support and inform all patient partnership activities
The Patient & Caregiver Engagement Working Group will provide oversight, operational direction, and ongoing technical, logistical, and administrative support for THRIVE patient engagement work. This work will occur through:
- A Patient & Caregiver Panel to provide input feedback and guidance to THRIVE research, communication, outreach and engagement activities.
- Site-level patient engagement activities to be developed as a component of the full-scale trial
- Additional patient engagement efforts to be determined over the course of the study
Patient Partnership Program Manager
Mara Bollini, BSN, MHA
Patient Partnership Faculty & Patient Leads
Mark Neuman, MD
Hugo Campos
Larry Chu, MD MS
Amy Price, DPhil
Roya Saffary, MD